Summary
This Form 8-K filing from Quest Diagnostics Incorporated (DGX) reports on the outcomes of their Annual Meeting of Shareholders held on May 6, 2010. The primary focus is on the election of directors and the ratification of the appointment of their independent auditor. All presented director nominees received a significant majority of votes in favor of their election, indicating strong shareholder confidence in the current board leadership and direction. Furthermore, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010, was overwhelmingly ratified by shareholders. This suggests continued trust in the firm's ability to provide an accurate and independent audit of Quest Diagnostics' financial statements, a crucial element for investor confidence and regulatory compliance.
Key Highlights
- 1Quest Diagnostics held its Annual Meeting of Shareholders on May 6, 2010.
- 2Three director nominees (John C. Baldwin, M.D., Surya N. Mohapatra, Ph.D., and Gary M. Pfeiffer) were elected for terms expiring at the 2013 Annual Meeting.
- 3All director nominees received substantial support, with over 140 million 'For' votes each.
- 4The company's existing directors (Jenne K. Britell, Ph.D., William F. Buehler, Rosanne Haggerty, Daniel C. Stanzione, Ph.D., Gail R. Wilensky, Ph.D., and John B. Ziegler) continue their terms.
- 5PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2010.
- 6The ratification of the auditor received overwhelming approval, with over 151 million 'For' votes.